Global Cancer Tissue Diagnostics Market Growth (Status and Outlook) 2025-2031

September 2025 | 96 pages | ID: G931B26FFA2BEN
LP Information

Abstracts

According to this study, the global Cancer Tissue Diagnostics market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Cancer Tissue Diagnostics Industry Forecast” looks at past sales and reviews total world Cancer Tissue Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Cancer Tissue Diagnostics sales for 2025 through 2031. With Cancer Tissue Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Tissue Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Cancer Tissue Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cancer Tissue Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Tissue Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Tissue Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Tissue Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Tissue Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Immunohistochemistry (IHC) Test
• In Situ Hybridisation Test

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Bio Rad Laboratories Inc.
• Abbott
• Enzo Life Sciences, Inc.
• Agilent Technologies, Inc.
• Cancer Genetics Inc.
• Merck KGaA (Sigma-Aldrich Co. LLC)
• Abcam plc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Tissue Diagnostics Market Size (2020-2031)
  2.1.2 Cancer Tissue Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cancer Tissue Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Cancer Tissue Diagnostics Segment by Type
  2.2.1 Immunohistochemistry (IHC) Test
  2.2.2 In Situ Hybridisation Test
2.3 Cancer Tissue Diagnostics Market Size by Type
  2.3.1 Cancer Tissue Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cancer Tissue Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Cancer Tissue Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Cancer Tissue Diagnostics Market Size by Application
  2.5.1 Cancer Tissue Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cancer Tissue Diagnostics Market Size Market Share by Application (2020-2025)

3 CANCER TISSUE DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Cancer Tissue Diagnostics Market Size Market Share by Player
  3.1.1 Global Cancer Tissue Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Cancer Tissue Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANCER TISSUE DIAGNOSTICS BY REGION

4.1 Cancer Tissue Diagnostics Market Size by Region (2020-2025)
4.2 Global Cancer Tissue Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cancer Tissue Diagnostics Market Size Growth (2020-2025)
4.4 APAC Cancer Tissue Diagnostics Market Size Growth (2020-2025)
4.5 Europe Cancer Tissue Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Cancer Tissue Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cancer Tissue Diagnostics Market Size by Country (2020-2025)
5.2 Americas Cancer Tissue Diagnostics Market Size by Type (2020-2025)
5.3 Americas Cancer Tissue Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cancer Tissue Diagnostics Market Size by Region (2020-2025)
6.2 APAC Cancer Tissue Diagnostics Market Size by Type (2020-2025)
6.3 APAC Cancer Tissue Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025)
7.2 Europe Cancer Tissue Diagnostics Market Size by Type (2020-2025)
7.3 Europe Cancer Tissue Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Tissue Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Cancer Tissue Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANCER TISSUE DIAGNOSTICS MARKET FORECAST

10.1 Global Cancer Tissue Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global Cancer Tissue Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas Cancer Tissue Diagnostics Forecast
  10.1.3 APAC Cancer Tissue Diagnostics Forecast
  10.1.4 Europe Cancer Tissue Diagnostics Forecast
  10.1.5 Middle East & Africa Cancer Tissue Diagnostics Forecast
10.2 Americas Cancer Tissue Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market Cancer Tissue Diagnostics Forecast
  10.2.2 Canada Market Cancer Tissue Diagnostics Forecast
  10.2.3 Mexico Market Cancer Tissue Diagnostics Forecast
  10.2.4 Brazil Market Cancer Tissue Diagnostics Forecast
10.3 APAC Cancer Tissue Diagnostics Forecast by Region (2026-2031)
  10.3.1 China Cancer Tissue Diagnostics Market Forecast
  10.3.2 Japan Market Cancer Tissue Diagnostics Forecast
  10.3.3 Korea Market Cancer Tissue Diagnostics Forecast
  10.3.4 Southeast Asia Market Cancer Tissue Diagnostics Forecast
  10.3.5 India Market Cancer Tissue Diagnostics Forecast
  10.3.6 Australia Market Cancer Tissue Diagnostics Forecast
10.4 Europe Cancer Tissue Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market Cancer Tissue Diagnostics Forecast
  10.4.2 France Market Cancer Tissue Diagnostics Forecast
  10.4.3 UK Market Cancer Tissue Diagnostics Forecast
  10.4.4 Italy Market Cancer Tissue Diagnostics Forecast
  10.4.5 Russia Market Cancer Tissue Diagnostics Forecast
10.5 Middle East & Africa Cancer Tissue Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cancer Tissue Diagnostics Forecast
  10.5.2 South Africa Market Cancer Tissue Diagnostics Forecast
  10.5.3 Israel Market Cancer Tissue Diagnostics Forecast
  10.5.4 Turkey Market Cancer Tissue Diagnostics Forecast
10.6 Global Cancer Tissue Diagnostics Forecast by Type (2026-2031)
10.7 Global Cancer Tissue Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cancer Tissue Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 F. Hoffmann-La Roche Ltd.
  11.1.1 F. Hoffmann-La Roche Ltd. Company Information
  11.1.2 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product Offered
  11.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.1.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.2 Danaher Corporation
  11.2.1 Danaher Corporation Company Information
  11.2.2 Danaher Corporation Cancer Tissue Diagnostics Product Offered
  11.2.3 Danaher Corporation Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Danaher Corporation Main Business Overview
  11.2.5 Danaher Corporation Latest Developments
11.3 Thermo Fisher Scientific Inc.
  11.3.1 Thermo Fisher Scientific Inc. Company Information
  11.3.2 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product Offered
  11.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.3.5 Thermo Fisher Scientific Inc. Latest Developments
11.4 Bio Rad Laboratories Inc.
  11.4.1 Bio Rad Laboratories Inc. Company Information
  11.4.2 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product Offered
  11.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bio Rad Laboratories Inc. Main Business Overview
  11.4.5 Bio Rad Laboratories Inc. Latest Developments
11.5 Abbott
  11.5.1 Abbott Company Information
  11.5.2 Abbott Cancer Tissue Diagnostics Product Offered
  11.5.3 Abbott Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Abbott Main Business Overview
  11.5.5 Abbott Latest Developments
11.6 Enzo Life Sciences, Inc.
  11.6.1 Enzo Life Sciences, Inc. Company Information
  11.6.2 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product Offered
  11.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Enzo Life Sciences, Inc. Main Business Overview
  11.6.5 Enzo Life Sciences, Inc. Latest Developments
11.7 Agilent Technologies, Inc.
  11.7.1 Agilent Technologies, Inc. Company Information
  11.7.2 Agilent Technologies, Inc. Cancer Tissue Diagnostics Product Offered
  11.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Agilent Technologies, Inc. Main Business Overview
  11.7.5 Agilent Technologies, Inc. Latest Developments
11.8 Cancer Genetics Inc.
  11.8.1 Cancer Genetics Inc. Company Information
  11.8.2 Cancer Genetics Inc. Cancer Tissue Diagnostics Product Offered
  11.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Cancer Genetics Inc. Main Business Overview
  11.8.5 Cancer Genetics Inc. Latest Developments
11.9 Merck KGaA (Sigma-Aldrich Co. LLC)
  11.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Information
  11.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product Offered
  11.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Main Business Overview
  11.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Latest Developments
11.10 Abcam plc.
  11.10.1 Abcam plc. Company Information
  11.10.2 Abcam plc. Cancer Tissue Diagnostics Product Offered
  11.10.3 Abcam plc. Cancer Tissue Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Abcam plc. Main Business Overview
  11.10.5 Abcam plc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cancer Tissue Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cancer Tissue Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunohistochemistry (IHC) Test
Table 4. Major Players of In Situ Hybridisation Test
Table 5. Cancer Tissue Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Cancer Tissue Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Cancer Tissue Diagnostics Market Size Market Share by Type (2020-2025)
Table 8. Cancer Tissue Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Cancer Tissue Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Cancer Tissue Diagnostics Market Size Market Share by Application (2020-2025)
Table 11. Global Cancer Tissue Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Cancer Tissue Diagnostics Revenue Market Share by Player (2020-2025)
Table 13. Cancer Tissue Diagnostics Key Players Head office and Products Offered
Table 14. Cancer Tissue Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cancer Tissue Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Cancer Tissue Diagnostics Market Size Market Share by Region (2020-2025)
Table 19. Global Cancer Tissue Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Cancer Tissue Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Cancer Tissue Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Cancer Tissue Diagnostics Market Size Market Share by Country (2020-2025)
Table 23. Americas Cancer Tissue Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Cancer Tissue Diagnostics Market Size Market Share by Type (2020-2025)
Table 25. Americas Cancer Tissue Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Cancer Tissue Diagnostics Market Size Market Share by Application (2020-2025)
Table 27. APAC Cancer Tissue Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Cancer Tissue Diagnostics Market Size Market Share by Region (2020-2025)
Table 29. APAC Cancer Tissue Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Cancer Tissue Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Cancer Tissue Diagnostics Market Size Market Share by Country (2020-2025)
Table 33. Europe Cancer Tissue Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Cancer Tissue Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Cancer Tissue Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cancer Tissue Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cancer Tissue Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cancer Tissue Diagnostics
Table 39. Key Market Challenges & Risks of Cancer Tissue Diagnostics
Table 40. Key Industry Trends of Cancer Tissue Diagnostics
Table 41. Global Cancer Tissue Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Cancer Tissue Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Cancer Tissue Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Cancer Tissue Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. F. Hoffmann-La Roche Ltd. Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 46. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product Offered
Table 47. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. F. Hoffmann-La Roche Ltd. Main Business
Table 49. F. Hoffmann-La Roche Ltd. Latest Developments
Table 50. Danaher Corporation Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 51. Danaher Corporation Cancer Tissue Diagnostics Product Offered
Table 52. Danaher Corporation Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Danaher Corporation Main Business
Table 54. Danaher Corporation Latest Developments
Table 55. Thermo Fisher Scientific Inc. Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 56. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product Offered
Table 57. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Thermo Fisher Scientific Inc. Main Business
Table 59. Thermo Fisher Scientific Inc. Latest Developments
Table 60. Bio Rad Laboratories Inc. Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 61. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product Offered
Table 62. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bio Rad Laboratories Inc. Main Business
Table 64. Bio Rad Laboratories Inc. Latest Developments
Table 65. Abbott Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 66. Abbott Cancer Tissue Diagnostics Product Offered
Table 67. Abbott Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Abbott Main Business
Table 69. Abbott Latest Developments
Table 70. Enzo Life Sciences, Inc. Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 71. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product Offered
Table 72. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Enzo Life Sciences, Inc. Main Business
Table 74. Enzo Life Sciences, Inc. Latest Developments
Table 75. Agilent Technologies, Inc. Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 76. Agilent Technologies, Inc. Cancer Tissue Diagnostics Product Offered
Table 77. Agilent Technologies, Inc. Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Agilent Technologies, Inc. Main Business
Table 79. Agilent Technologies, Inc. Latest Developments
Table 80. Cancer Genetics Inc. Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 81. Cancer Genetics Inc. Cancer Tissue Diagnostics Product Offered
Table 82. Cancer Genetics Inc. Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Cancer Genetics Inc. Main Business
Table 84. Cancer Genetics Inc. Latest Developments
Table 85. Merck KGaA (Sigma-Aldrich Co. LLC) Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 86. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product Offered
Table 87. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Merck KGaA (Sigma-Aldrich Co. LLC) Main Business
Table 89. Merck KGaA (Sigma-Aldrich Co. LLC) Latest Developments
Table 90. Abcam plc. Details, Company Type, Cancer Tissue Diagnostics Area Served and Its Competitors
Table 91. Abcam plc. Cancer Tissue Diagnostics Product Offered
Table 92. Abcam plc. Cancer Tissue Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Abcam plc. Main Business
Table 94. Abcam plc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Tissue Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Tissue Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cancer Tissue Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cancer Tissue Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Cancer Tissue Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cancer Tissue Diagnostics Market Size Market Share by Type in 2024
Figure 10. Cancer Tissue Diagnostics in Hospitals
Figure 11. Global Cancer Tissue Diagnostics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Cancer Tissue Diagnostics in Clinics
Figure 13. Global Cancer Tissue Diagnostics Market: Clinics (2020-2025) & ($ millions)
Figure 14. Cancer Tissue Diagnostics in Others
Figure 15. Global Cancer Tissue Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Cancer Tissue Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global Cancer Tissue Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global Cancer Tissue Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Cancer Tissue Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC Cancer Tissue Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe Cancer Tissue Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Cancer Tissue Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas Cancer Tissue Diagnostics Value Market Share by Country in 2024
Figure 24. United States Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Cancer Tissue Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC Cancer Tissue Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Cancer Tissue Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Cancer Tissue Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe Cancer Tissue Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Cancer Tissue Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Cancer Tissue Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Cancer Tissue Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Cancer Tissue Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Cancer Tissue Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global Cancer Tissue Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Cancer Tissue Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Cancer Tissue Diagnostics Market Size 2026-2031 ($ millions)